GEODE
LIVE

Serial Number

90664301

Owner

Tectonic Therapeutic, Inc.

Attorney

Wade Savoy

First Use Date

Mar 20, 2023

Filing Date

Apr 22, 2021

Add to watchlist:

No watchlists yet
View on USPTO

GEODE Trademark

Serial Number: 90664301

GEODE is a trademark filed by Tectonic Therapeutic, Inc. on April 22, 2021. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Tectonic Therapeutic, Inc.

Watertown, MA 02472

Entity Type: 03

Trademark Details

Filing Date

April 22, 2021

Registration Date

Not Registered

First Use Anywhere

March 20, 2023

First Use in Commerce

March 20, 2023

Published for Opposition

April 5, 2022

Goods & Services

Biotechnology and pharmaceutical testing, research, development, and analysis; pharmaceutical, biomedical, and biological therapeutic research and services; pharmaceutical research and development; biological research services; research and development services in the pharmaceutical and biopharmaceutical fields; research and development services in the pharmaceutical and biopharmaceutical fields, namely, in the field of technologies related to proteins and G-protein-coupled receptors (GPCRs); research services in biology fields; pharmaceutical research services in biological drug discovery and development; pharmaceutical research and development services for identifying lead biologics; research and development services in the creation of libraries or collections of biologicals; pharmaceutical research and development in the nature of research, creation, and development of biological drug targets for non-medical scientific screening purposes; pharmaceutical research, analysis, and examination for identification of biologics through automated screening processes; laboratory research, screening, evaluation, and development of biologics; research, studies, and development in the field of pharmaceuticals and biologics; research and development services in biological pharmaceutical development; medical and pharmacological research services; analysis and measurement of pharmaceutical, biomedical, and biological molecules and characteristics; bioanalysis services; biochemical analysis; research and development of medicines; research and development services in the field of antibodies and small proteins; research and development services in the field of antibody and small protein technology; research relating to molecular sciences; research relating to pharmaceuticals; scientific and pharmaceutical research and development, namely, use of in silico, in vitro, and in vivo methods and procedures for biologic, drug, and target production, manipulation, screening, selection, and assaying; provision of information, advisory services, and consultancy relating to the aforesaid services

Filing History

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 11, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 11, 2026 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 10, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 10, 2026 CRFA
ASSIGNED TO LIE
Feb 10, 2026 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 3, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 6, 2025 GNRN
NON-FINAL ACTION E-MAILED
Nov 6, 2025 GNRT
SU - NON-FINAL ACTION - WRITTEN
Nov 6, 2025 CNRT
ASSIGNED TO EXAMINER
Oct 28, 2025 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 27, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 27, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 27, 2025 REAP
STATEMENT OF USE PROCESSING COMPLETE
May 26, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 22, 2024 AITU
USE AMENDMENT FILED
Apr 25, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Apr 25, 2024 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 10, 2023 EXRA
SOU EXTENSION 3 GRANTED
Nov 8, 2023 EX3G
SOU EXTENSION 3 FILED
Nov 8, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 8, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 20, 2023 EXRA
SOU EXTENSION 2 GRANTED
Apr 18, 2023 EX2G
SOU EXTENSION 2 FILED
Apr 18, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 18, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 11, 2022 EXRA
SOU EXTENSION 1 GRANTED
Nov 9, 2022 EX1G
SOU EXTENSION 1 FILED
Nov 9, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 9, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 31, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 5, 2022 NPUB
PUBLISHED FOR OPPOSITION
Apr 5, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 16, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 1, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 1, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 1, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 1, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 1, 2022 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 10, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jan 10, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jan 10, 2022 CNRT
ASSIGNED TO EXAMINER
Dec 16, 2021 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 2, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 2, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 2, 2021 REAP
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 29, 2021 NWOS
NEW APPLICATION ENTERED
Apr 26, 2021 NWAP